American Herbal Products Association (AHPA) > News > Alerts

AHPA submits comments to DEA on potential impacts of scheduling herbal constituents

December 2016: DEA should avoid restricting research on new medical uses, health benefits, or other uses for botanicals

In comments submitted last week to the Drug Enforcement Agency (DEA), the American Herbal Products Association (AHPA) urged the agency to refrain from using its authority to effectively remove a plant from the existing marketplace because naturally occurring constituents become scheduled under the Controlled Substances Act (CSA).

AHPA submits comments to FTC regarding consumer perceptions of "organic" claims

December 2016: Many personal care products and dietary supplements are produced in compliance with USDA's National Organic Progam

AHPA stressed that non-food products, including personal care products, may be agricultural products that can comply with the United States Department of Agriculture (USDA) National Organic Program (NOP).

"Incidental DNA fragments" may be misinterpreted using Next Generation Sequencing (NGS)

October 19. 2016: A caution to industry and regulators

This article, "A caution to industry and regulators - 'Incidental DNA fragments' may be misinterpreted using Next Generation Sequencing (NGS)," is authored by Dr. Steven Newmaster, Professor, Botany & Genetics/Genomics at the University of Guelph, Dr. Subramanyam Ragupathy, Senior Scientist, NHP Molecular Diagnostics at the Biodiversity Institute of Ontario, and Dr. Robert Hanner, Chief Technology Officer (CTO) at TRU-ID Ltd. These leading DNA experts detai challenges and pitfalls of DNA analysis used to verify the identity of herbal ingredients.

FDA Seeks Comment on Tentative Conclusion that Vinpocetine Is not a Dietary Ingredient

FDA maintains vinpocetine is a synthetic compound

A Food and Drug Administration (FDA) notice scheduled to be published tomorrow in the Federal Register requests comments on the agency's tentative conclusion that vinpocetine is not a dietary ingredient and is excluded from the definition of a dietary supplement.

Report from the 2016 Conference of Western Attorneys General Annual Meeting

By Douglas F. Gansler

In January, AHPA and UNPA launched a joint campaign to develop working relationships with state attorneys general (AG) and educate them about the herbal supplement industry to ensure they have an accurate understanding of the industry. Former Maryland Attorney General and Past President of the National Association of Attorneys General. Gansler was hired to help deliver information and expertise about the industry to his colleagues.

FDA Releases Revised Draft of NDI Guidance

August 2016: Revised draft replaces FDA’s 2011 draft

The Food and Drug Administration (FDA) today released revised draft guidance for new dietary ingredients (NDIs) to be published in the Federal Register on Friday. The revised draft replaces FDA’s 2011 draft.

AHPA Presents on GACP and GMP for Herbal Ingredients at ACI Conference

June 2016: AHPA leading industry consensus process for creation of self-regulatory initiatives

American Herbal Products Association (AHPA) President Michael McGuffin discussed development of good agricultural and collection practices (GACP) and good manufacturing practice (GMP) in the herbal ingredient supply chain on June 28 at the American Conference Institute's (ACI's) fourth annual Legal, Regulatory, and Compliance Forum on Dietary Supplements in New York City.

AHPA Urges FDA to Define "Natural" to Promote Clarity and Consistency

May 2016: Consumers should not be misled by inconsistent or inaccurate uses of "natural"

The American Herbal Products Association (AHPA) submitted comments to the Food and Drug Administration (FDA) yesterday encouraging the agency to establish, through rulemaking, a regulatory definition for the term "natural" (and possibly other terms, such as "100% natural" and "made with natural [named ingredient(s)]") for the labeling of human food products, and other products regulated by FDA such as animal foods, cosmetics, and botanical drugs.

Aveda and the Estée Lauder Companies Support Conservation of Candelilla in Mexico

AHPA ERB Foundation announces $10,000 grant donated to CONABIO

The American Herbal Products Association Foundation for Education and Research on Botanicals (AHPA ERB Foundation) announced today that a grant of $10,000 USD has been donated to CONABIO, the national agency responsible for Biodiversity Information and the CITES Scientific Authority in Mexico.

AHPA opposes U.S. Customs proposal to reclassify certain bilberry and blueberry extracts

January 2016: AHPA Update

AHPA works to maintain appropriate tariff classifications for botanical extracts


	Address: 8630 Fenton Street, Suite 918, Silver Spring, MD 20910 Phone: 301.588.1171 Email: ahpa@ahpa.org ©Copyright 2022 AHPA

Market Alerts

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

August 2021

July 2021

March 2021

February 2021

November 2020

October 2020

September 2020

August 2020

July 2020

June 2020

April 2020

February 2020

January 2020

August 2019

June 2019

May 2019

March 2019

February 2019

January 2019

December 2018

November 2018

October 2018

September 2018

August 2018

July 2018

May 2018

April 2018

March 2018

February 2018

January 2018

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017